Vaccins prophylactiques antipapillomavirus : enjeux et perspectives
- 31 August 2006
- journal article
- abstracts
- Published by Elsevier in Gynécologie Obstétrique & Fertilité
- Vol. 34 (7-8) , 647-655
- https://doi.org/10.1016/j.gyobfe.2006.05.008
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial NeoplasiaObstetrics & Gynecology, 2006
- Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicityReviews in Medical Virology, 2005
- Against which human papillomavirus types shall we vaccinate and screen? the international perspectiveInternational Journal of Cancer, 2004
- Épidémiologie de l’infection à HPVGynécologie Obstétrique & Fertilité, 2004
- Infections à papillomavirusEMC - Maladies Infectieuses, 2004
- Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus-Like ParticlesJNCI Journal of the National Cancer Institute, 2003
- The causal relation between human papillomavirus and cervical cancerJournal of Clinical Pathology, 2002
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human seraJournal of General Virology, 1994